Open AccessClopidogrel response is defined by CYP2C19 metabolizer status in patients undergoing percutaneous neurointervention procedure.
Author(s) -
Miriam Sáiz Rodríguez,
Daniel R. Romero Palacián,
Carlos Villalobos Vilda,
Carmen Belmonte,
Dóra Koller,
María Talegón,
Francisco Abad Santos,
Eduardo Bárcena,
José Luis Caniego,
Carmen Belmonte,
Francisco Abad Santos,
Francisco Abad Santos
Publication year - 2018
Publication title -
ibj plus
Language(s) - English
Resource type - Journals
ISSN - 2531-0151
DOI - 10.24217/2531-0151.18v1s2.00116
Subject(s) - cyp2c19 , clopidogrel , medicine , percutaneous , cardiology , aspirin , cytochrome p450 , metabolism